HUMANISTIC BURDEN OF MIGRAINE IN THE EU5- A MATCHED ANALYSIS OF THE NATIONAL HEALTH AND WELLNESS SURVEY (NHWS) 2017

Author(s)

Doane MJ1, Vo P2, Bilitou A3, Fang J4, Laflamme A2, Gupta S5
1Kantar Health, Horsham, PA, USA, 2Novartis Pharma AG, Basel, Switzerland, 3Novartis Global Services Centre, Dublin, Ireland, 4Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 5Kantar Health, New York, NY, USA

OBJECTIVES: The purpose of this study was to describe the incremental burden of migraine on health-related quality of life (HRQoL) in those suffering from migraine of ≥4 monthly headache days (HDs) compared with matched controls in Europe. METHODS: A retrospective, cross-sectional analysis was conducted using self-reported data from the 2017 EU5 National Health and Wellness Survey (NHWS). Outcomes from 1,569 adult respondents, who self-reported a physician diagnosis of migraine, experiencing at least one migraine in the prior month and overall ≥4 HDs during the prior month, were stratified by HD frequency (4-7, 8-14 and ≥15 HDs) and matched by propensity scores to 1,569 respondents without migraine (controls) using sociodemographic characteristics. HRQoL was assessed via Short Form-36 (SF-36v2) and EuroQol (EQ-5D). Independent samples t-tests were used for pairwise comparisons of outcomes across subgroups. RESULTS: Both SF-6D and EQ-5D scores were significantly lower in 783 respondents with 4-7 HDs (0.64 and 0.75, respectively), 429 respondents with 8-14 HDs (0.63 and 0.73) and 357 respondents with ≥15 HDs (0.58 and 0.58) compared with non-migraine controls (0.70 and 0.83). Both Mental (MCS) and Physical Component Summary (PCS) scores were significantly lower across migraine subgroups compared with non-migraine controls (MCS: 41.02 4-7HDs, 40.03 8-14HDs and 36.52 ≥15HDs vs. 45.17 controls; PCS: 48.11 4-7HDs, 47.15 8-14HDs and 42.69 ≥15HDs vs. 50.87 controls). CONCLUSIONS: Individuals with migraine across migraine frequency subgroups report significantly worse HRQoL compared with those without migraine, indicative of the burden that exists across the spectrum of migraine patients who may be eligible for preventive treatment.

Conference/Value in Health Info

2018-11, ISPOR Europe 2018, Barcelona, Spain

Value in Health, Vol. 21, S3 (October 2018)

Code

PND151

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Neurological Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×